BLKB three-lens brief
Evidence-based stock research on BLKB. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA above 200-day MA (golden-cross regime); price above both. · Debt-to-equity of 880% — balance-sheet-heavy.
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- Outperforming SPY by 31.1pp over 30 days.
- Debt-to-equity of 880% — balance-sheet-heavy.
BLKB closed at $54.40 (-0.95%) as of 2026-11-12. Market cap: $2.45B. P/E (trailing) 16.7. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; outperforming SPY by 31.1pp over 30 days.. Concerns: debt-to-equity of 880% — balance-sheet-heavy.. Last quarter: Revenue $292.64M, net income $46.07M, free cash flow $204.64M.
Why three lenses on BLKB, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BLKB across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/BLKB" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BLKB brief"></iframe>